Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1705-1709

  Srinivas, Shamala K ^b   Sample, Jeffery T ^b   Sixbey, John W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; DNA REPLICATION; EPISOME; EPSTEIN BARR VIRUS; GENETIC STABILITY; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION;

EID: 0031750736     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517427     Document Type: Article

References (15)

1. Rickinson AB, Kieff E. The Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields virology. 3rd ed. Philadelphia: Lippincott-Raven, 1996:2397-446.
2. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
3. Neri A, Barriga F, Inghirami G, et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991;77:1092-5.
4. Gregory CD, Rowe M, Rickinson AB. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 1990;71:1481-95.
5. Trivedi P, Zhang QJ, Chen F, et al. Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma. Oncogene 1995;11:505-10.
6. Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey JW. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis 1996;173:529-35.
7. Polack A, Hartl G, Zimber U, et al. A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates. Gene 1984;27: 279-88.
8. Shapiro DN, Valentine MB, Rowe S, et al. Detection of N-myc gene amplification by fluorescence in situ hybridization. Am J Pathol 1993; 142:1339-46.
9. Rowe M, Rowe DT, Gregory CD, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 1987;6:2743-51.
10. Miller G, Rabson M, Heston L. Epstein-Barr virus with heterogeneous DNA disrupts latency. J Virol 1984;50:174-82.
11. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: evidence for a "hit-and-run" mechanism. Nature 1983;302: 21-4.
12. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 1994;68:6069-73.
13. Delecluse HJ, Bartnizke S, Hammerschmidt W, Bullerdiek J, Bornkamm GW. Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cells. J Virol 1993;67:1292-9.
14. Rooney C, Taylor N, Countryman J, Jenson H, Kolman J, Miller G. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc Natl Acad Sci USA 1988;85:9801-5.
15. Takada K, Ji Z, Fujiwara S, Shimizu N, Tanabe-Tochikura A. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene. J Virol 1992;66:5590-3.